• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

MIRASOL trial and DESTINY-PanTumor02 Trial Overview

Opinion
Video

Ronald D. Alvarez, MD, MBA, gives an analysis of the MIRASOL and DESTINY-PanTumor02 trials, including a comparison of study arms and discussion of HER2/neu targeting.

Related Videos
1 expert is featured in this series.
5 experts are featured in this series
5 experts are featured in this series.
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.